Key takeaways for Connecticut
- • No GLP-1 is FDA-approved for pre/post-bariatric use specifically.
- • Pre-op: liver shrinkage and risk optimization; post-op: regain management.
- • Observational data show 8-15% additional weight loss post-op on GLP-1.
- • HUSKY Health coverage rules apply for Bariatric Pre- and Post-Op Support patients in Connecticut — see Medicaid section below.
- • 13 GLP-1 telehealth providers available nationwide.
Why GLP-1 medications for Bariatric Pre- and Post-Op Support
No GLP-1 is FDA-approved specifically for bariatric pre/post-op support. Off-label preoperative use can reduce liver volume and improve surgical access; off-label postoperative use addresses the roughly 25-30% of bariatric patients who experience clinically significant weight regain. Evidence grade: C (observational data growing; few RCTs). The ASMBS 2022 statement and emerging 2024-2025 consensus recognize this as an evolving practice. Pancreatitis and gastroparesis risks may merit extra caution in altered post-op anatomy.
Connecticut-specific context
Connecticut has telehealth access concentrated in Bridgeport, New Haven, Stamford metros, with additional reach to Hartford and Waterbury. Yale New Haven Health is the largest in-state academic medical center for endocrine + obesity-medicine specialty consults. The state health authority publishes prescribing + coverage updates at portal.ct.gov/dph.
Connecticuttelehealth & pricing rules
- • Connecticut requires a live video consultation before a GLP-1 prescription.
- • Connecticut allows new-patient telehealth prescribing without a prior in-person visit.
- • Typical cash GLP-1 price in Connecticut: ~$325/mo (compounded options often lower, brand higher).
State telehealth statutes change — verify current rules with your provider before booking.